Brechbiel, Martin W.
Cancer Biotherapy and Radiopharmaceuticals,
United States
2025 Rank: 25201
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 128 out of 122662 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25201 | 23655 |
| Total Cites | 19715 | 23631 |
| H-index | 76 | 84 |
| Hm-index | 34 | 37 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 272 | 279 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 762 | 893 |
| Number of Single+First+Last Authored Papers | 178 | 178 |
| Total Cites to Single+First+Last Authored Papers | 9322 | 10839 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12001 | 12958 |
| Ratio of Total Citations to Distinct Citing Papers | 1.64 | 1.82 |
| Self-Citation Percentage |
16.57%
|
|
Brechbiel, Martin W.
Cancer Biotherapy and Radiopharmaceuticals,
United States
2024 Rank: 24248
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 123 out of 116246 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24248 | 22583 |
| Total Cites | 18996 | 22864 |
| H-index | 74 | 83 |
| Hm-index | 33 | 37 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 257 | 264 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 733 | 864 |
| Number of Single+First+Last Authored Papers | 177 | 177 |
| Total Cites to Single+First+Last Authored Papers | 8918 | 10420 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11518 | 12445 |
| Ratio of Total Citations to Distinct Citing Papers | 1.65 | 1.84 |
| Self-Citation Percentage |
16.92%
|
|
Brechbiel, Martin W.
Cancer Biotherapy and Radiopharmaceuticals,
Italy
2023 Rank: 23342
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 120 out of 109758 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23342 | 21631 |
| Total Cites | 18328 | 22175 |
| H-index | 72 | 81 |
| Hm-index | 33 | 36 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 237 | 244 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 712 | 842 |
| Number of Single+First+Last Authored Papers | 176 | 176 |
| Total Cites to Single+First+Last Authored Papers | 8556 | 10054 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11066 | 11985 |
| Ratio of Total Citations to Distinct Citing Papers | 1.66 | 1.85 |
| Self-Citation Percentage |
17.35%
|
|
Brechbiel, Martin W.
National Cancer Institute (NCI),
United States
2021 Rank: 22652
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 121 out of 101860 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22652 | 20651 |
| Total Cites | 16730 | 20477 |
| H-index | 69 | 78 |
| Hm-index | 31 | 35 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 201 | 206 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 645 | 770 |
| Number of Single+First+Last Authored Papers | 174 | 174 |
| Total Cites to Single+First+Last Authored Papers | 7703 | 9182 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 10125 | 11014 |
| Ratio of Total Citations to Distinct Citing Papers | 1.65 | 1.86 |
| Self-Citation Percentage |
18.30%
|
|